Loma Linda University

Enrollment Information
Call us at: 909-558-1000

Faculty Directory
  
Yuan Yuan, MD, PhD
Assistant Professor, Medicine
School of Medicine
Presentations    Research Presentations -- Local/Campus
  • Yuan Y., Ma H., Cohen D., Hochster H.S. et al. Activity and tolerance of biweekly CapeOx-Cetuximab in 1st line therapy of metastatic colorectal cancer (mCRC): relation to K-ras mutation status. (ASCO 2009 Annual Meeting) ( 0/2009 )
  • Yuan Y., Ma H., Cohen D., Hochster H.S. et al. Activity and excellent tolerance of biweekly cetuximab, oxaliplatin, and capecitabine in 1st line therapy of metastatic colorectal cancer with effects of K-ras (2009 ASCO GI symposium) ( 0/2009 )
  • Yuan Y., Wang, N., Zhu, Y., Liao, HL., Stemerman,  M.B. and Verna, L.K. Cholesterol-induced cell signaling in the endothelium. International Society of Thrombosis and Homeostasis Paris, France. July 8, 2001 ( 7/2008 )
  • Yuan Y., Omene C., Green D., Araten D., Ballard H. A Relapsed Multiple Myeloma with Multiple Soft Tissue Plasmacytoma of the Extremities and Diffuse Pulmonary Parenchymal Involvement. Annual Research Conference of Department of Medicine, New York University Medical Center, 2008 ( 0/2008 )
  • Yuan Y., Muggia F., et al PLD: Enhanced skin toxicity in areas of vitiligo (2008 Ecancermedicalscience) ( 0/2008 )
  • Petrovan R.J., Yuan Y., Curtiss L.K. Atherosclerosis in Apolipoprotein E-Deficient Mice with the Lystbeige Mutation. Annual Research Conference of Department of Medicine, New York University Medical Center, 2004 ( 0/2004 )
  • Yuan Y., Cohen D., Hochster H.S. et al. Phase I/II dose-escalating study of bi-weekly Pemetrexed and fixed dose rate Gemcitabine in patients advanced solid tumors (In preparation). (*)